Beruflich Dokumente
Kultur Dokumente
Page 1 of 3
English
Drug
Toxicity Enhanced By
No Change With
Drug
Toxicity Enhanced By
No Change With
Aminoglycosides
Cephalosporins
Clindamycin
Doxycycline
Tetracycline
Trimethoprim
Fluoroquinolones
Ketoconazole
Linezolid
Metronidazole
Penicillins
Quinulpristine/dalfopristin
Sulfonamides
Vancomycin
Phenytoin
Chloramphenicol
Azithromycin
Isoniazid
Cephalosporins
Ciprofloxacin
Aminoglycosides
Clindamycin
Doxycycline
Fluoroquinolones except
ciprofloxacin
Linezolid
Metronidazole
Penicillins
.
These drugs interfere with vitamin Kdependent clotting factors and, when used with antiplatelet drugs and
thrombolytics, may increase risk of bleeding.
http://www.merckmanuals.com/professional/infectious-diseases/... 05-Apr-16
Toxicity Enhanced By
No Change With
Quinulpristine/dalfopristin
Tetracycline
Trimethoprim
Vancomycin
Aminoglycosides
Azithromycin
Cephalosporins
Clindamycin
Ciprofloxacin
Theophylline
Clarithromycin
Erythromycin
Doxycycline
Linezolid
Metronidazole
Penicillins
Quinulpristine/dalfopristin
Sulfonamides
Tetracycline
Trimethoprim
Vancomycin
Warfarin*
Cefoperazone
Aminoglycosides (IV)
Chloramphenicol
Cephalosporins (some)
Doxycycline
Doxycycline
Penicillins
Cefotetan
Azithromycin
Clarithromycin
Clindamycin
Erythromycin
Linezolid
Metronidazole
Quinulpristine/dalfopristin
Tetracycline
Trimethoprim
.
These drugs interfere with vitamin Kdependent clotting factors and, when used with antiplatelet drugs and
thrombolytics, may increase risk of bleeding.
http://www.merckmanuals.com/professional/infectious-diseases/... 05-Apr-16
Toxicity Enhanced By
No Change With
Sulfonamides
Vancomycin
.
These drugs interfere with vitamin Kdependent clotting factors and, when used with antiplatelet drugs and
thrombolytics, may increase risk of bleeding.
http://www.merckmanuals.com/professional/infectious-diseases/... 05-Apr-16